Skip to main content
Premium Trial:

Request an Annual Quote

Letting Them in the House for Your Health

Intel and GE are teaming up to develop and sell home-based healthcare technology and plan to spend $250 million on research and development over the next five years, says the New York Times. The Wall Street Journal adds that GE chief Jeffrey Immelt said that these funds are "250 million real dollars" and that the companies think they will be helped indirectly by the government stimulus package. Also as part of this, GE will sell the Intel Health Guide that helps patients monitor their health at home and send that information to their physicians. GE also makes a product called QuietCare that uses motion sensors to track patients' daily activities to look for abnormalities that may indicate a fall or other health problems. "Health care has to go efficiently into the home, to enable elders to age in place with dignity," says Louis Burns, the general manager of Intel's digital health group.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.